author-photo

Howard Levy

University of New Mexico
Eli Lilly and Company

74

Papers

6083

Citations

Citation Trend

Filter By

Papers (74) Sort By

Journal Conference Others

Efficacy and safety of subcutaneous prophylaxis with dalcinonacog alfa in adults with haemophilia B.

2021 Haemophilia
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 14230: Effects of Oral Carbon Monoxide on Doxorubicin-Induced Cardiotoxicity

2021 Circulation
Show All
- Source
- Cite
- Save
Citations (0)
Safety, Pharmacokinetics and Pharmacodynamics of a Next-Generation Subcutaneously Administered Coagulation Factor IX Variant, Dalcinonacog Alfa, in Previously Treated Hemophilia B Patients.

2021 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (3)
Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1/2 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Marzeptacog Alfa (activated) in the Treatment of Episodic Bleeding in Subjects with Inherited Bleeding Disorders

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (6)
The Crimson 1 Study: A Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous Marzeptocog Alfa (activated) for on-Demand Treatment and Control of Bleeding Episodes in Subjects with Hemophilia A or Hemophilia B, with Inhibitors

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Combination of Marzeptacog Alfa (Activated) or Eptacog Alfa (Activated) with Emicizumab Appears Comparable As Assessed By the Thrombin Generation Test in Hemophilia a Plasma

2019 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Fast Onset of Action of Subcutaneously Administered Marzeptacog Alfa (Activated) Supports on-Demand Treatment in Hemophilia a Mice

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Opportunities for Improvement: The Lot of the Inhibitor Patient Is Not a Happy One

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)